Dr. med. Patrick Schmid
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard H, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stoeckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso R, Andre P, Girardin F, Guidi M, Buclin T, Decosterd L, Swiss HIV Cohort Study S. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. Lancet Reg Health Eur 2023; 36:100793.
Dec 13, 2023Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Dec 13, 2023Lancet Reg Health Eur 2023; 36:100793
Thoueille Paul, Alves Saldanha Susana, Schaller Fabian, Choong Eva, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldyrich F, Kusejko Katharina, Surial Bernard, Furrer Hansjakob, Rauch Andri, Rougemont Mathieu, Ustero Pilar, Calmy Alexandra, Stoeckle Marcel, Marzolini Catia, Di Benedetto Caroline, Bernasconi Enos, Schmid Patrick, Piso Rein Jan, Andre Pascal, Girardin François R, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Swiss HIV Cohort Study SHCS
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
Baumann L, Braun D, Cavassini M, Stoeckle M, Bernasconi E, Schmid P, Calmy A, Haerry D, Béguelin C, Fux C, Wandeler G, Surial B, Rauch A. Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study. Liver Int 2023; 44:169-179.
Oct 18, 2023Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
Oct 18, 2023Liver Int 2023; 44:169-179
Baumann Lukas, Braun Dominique Laurent, Cavassini Matthias, Stoeckle Marcel, Bernasconi Enos, Schmid Patrick, Calmy Alexandra, Haerry David, Béguelin Charles, Fux Christoph Andreas, Wandeler Gilles, Surial Bernard, Rauch Andri
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Begré L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, Béguelin C, Rockstroh J, Günthard H, Calmy A, Cavassini M, Stoeckle M, Schmid P, Bernasconi E, Levrero M, Zoulim F, Wandeler G, Rauch A, Swiss HIV Cohort Study (SHCS). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med 2023; 25:291-298.
Oct 10, 2023Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Oct 10, 2023HIV Med 2023; 25:291-298
Begré Lorin, Boyd Anders, Salazar-Vizcaya Luisa, Suter-Riniker Franziska, Béguelin Charles, Rockstroh J K, Günthard Huldyrich F, Calmy Alexandra, Cavassini Matthias, Stoeckle Marcel, Schmid Patrick, Bernasconi Enos, Levrero Massimo, Zoulim Fabien, Wandeler Gilles, Rauch Andri, Swiss HIV Cohort Study (SHCS)
Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'.
Bertisch B, Schaetti C, Schmid P, Peter L, Vernazza P, Isler M, Oppliger R, Schmidt A. Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'. J Viral Hepat 2023; 31:53-56.
Oct 7, 2023Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'.
Oct 7, 2023J Viral Hepat 2023; 31:53-56
Bertisch Barbara, Schaetti Christian, Schmid Patrick, Peter Laura, Vernazza Pietro L, Isler Marc, Oppliger Robert, Schmidt Axel Jeremias
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M, Frossard J, Kouyos R, Prendki V, Damas J, Hofmann E, Braun D, Schmid P, Bernasconi E, Ragozzino S, Efthimiou O, Delpierre C, Allavena C, Bani-Sadr F, Calmy A, Swiss HIV Cohort Study S. External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older. HIV Med 2023; 25:72-82.
Aug 24, 2023External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Aug 24, 2023HIV Med 2023; 25:72-82
Hentzien Maxime, Frossard Jaromil, Kouyos Roger D, Prendki Virginie, Damas José, Hofmann Eveline, Braun Dominique, Schmid Patrick, Bernasconi Enos, Ragozzino Silvio, Efthimiou Orestis, Delpierre Cyrille, Allavena Clotilde, Bani-Sadr Firouzé, Calmy Alexandra, Swiss HIV Cohort Study SHCS
Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.
Bertisch B, Schaetti C, Schmid P, Peter L, Vernazza P, Isler M, Oppliger R, Schmidt A. Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat 2023; 30:667-684.
Jun 6, 2023Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.
Jun 6, 2023J Viral Hepat 2023; 30:667-684
Bertisch Barbara, Schaetti Christian, Schmid Patrick, Peter Laura, Vernazza Pietro L, Isler Marc, Oppliger Robert, Schmidt Axel Jeremias
Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
Künzler-Heule P, Schmidt A, Fierz K, Battegay M, Engberg S, Kouyos R, Nöstlinger C, Stoeckle M, Béguelin C, Delaloye J, Schmid P, Rougemont M, Braun D, Fehr J, Nicca D. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care 2023:1-10.
May 14, 2023Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
May 14, 2023AIDS Care 2023:1-10
Künzler-Heule Patrizia, Schmidt Axel Jeremias, Fierz Katharina, Battegay Manuel, Engberg Sandra J, Kouyos Roger D, Nöstlinger Christiana, Stoeckle Marcel, Béguelin Charles, Delaloye Julie, Schmid Patrick, Rougemont Mathieu, Braun Dominique Laurent, Fehr Jan S, Nicca Dunja
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen.
Marzolini C, Cavassini M, Braun D, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Elzi L, Swiss HIV Cohort Study S. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen. Br J Clin Pharmacol 2023
Apr 26, 2023Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen.
Apr 26, 2023Br J Clin Pharmacol 2023
Marzolini Catia, Cavassini Matthias, Braun Dominique Laurent, Hachfeld Anna, Bernasconi Enos, Calmy Alexandra, Schmid Patrick, Battegay Manuel, Elzi Luigia, Swiss HIV Cohort Study SHCS
Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.
Apr 17, 2023Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Apr 17, 2023Front Med (Lausanne) 2023; 10:948787
Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner
Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared.
Hamusonde K, Nicca D, Günthard H, Stöckle M, Darling K, Calmy A, Bernasconi E, Haerry D, Schmid P, Kouyos R, Rauch A, Salazar-Vizcaya L. Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared. J Infect Dis 2022
Nov 21, 2022Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared.
Nov 21, 2022J Infect Dis 2022
Hamusonde Kalongo, Nicca Dunja, Günthard Huldrych F, Stöckle Marcel, Darling Katharine Ea, Calmy Alexandra, Bernasconi Enos, Haerry David, Schmid Patrick, Kouyos Roger D, Rauch Andri, Salazar-Vizcaya Luisa
Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.
Kusejko K, Salazar-Vizcaya L, Shah C, Stöckle M, Béguelin C, Schmid P, Ongaro M, Darling K, Bernasconi E, Rauch A, Kouyos R, Günthard H, Böni J, Fehr J, Braun D, Swiss HIV Cohort Study. Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program. Clin Infect Dis 2022; 75:1723-1731.
Nov 14, 2022Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program.
Nov 14, 2022Clin Infect Dis 2022; 75:1723-1731
Kusejko Katharina, Salazar-Vizcaya Luisa, Shah Cyril, Stöckle Marcel, Béguelin Charles, Schmid Patrick, Ongaro Marie, Darling Katherine, Bernasconi Enos, Rauch Andri, Kouyos Roger D, Günthard Huldrych F, Böni Jürg, Fehr Jan S, Braun Dominique L, Swiss HIV Cohort Study
Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men.
Andresen S, Balakrishna S, Mugglin C, Schmidt A, Braun D, Marzel A, Doco Lecompte T, Darling K, Roth J, Schmid P, Bernasconi E, Günthard H, Rauch A, Kouyos R, Salazar-Vizcaya L, Swiss HIV Cohort Study. Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men. PLoS Comput Biol 2022; 18:e1010559.
Oct 27, 2022Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men.
Oct 27, 2022PLoS Comput Biol 2022; 18:e1010559
Andresen Sara, Balakrishna Suraj, Mugglin Catrina, Schmidt Axel J, Braun Dominique L, Marzel Alex, Doco Lecompte Thanh, Darling Katharine Ea, Roth Jan A, Schmid Patrick, Bernasconi Enos, Günthard Huldrych F, Rauch Andri, Kouyos Roger D, Salazar-Vizcaya Luisa, Swiss HIV Cohort Study
The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
Mocroft A, Geressu A, Béguelin C, Llibre J, Lazarus J, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen L, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe. AIDS 2022; 37:91-103.
Oct 18, 2022The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
Oct 18, 2022AIDS 2022; 37:91-103
Mocroft Amanda, Geressu Adam, Béguelin Charles, Llibre Josep M, Lazarus Jeffrey V, Tomazic Janez, Smidt Jelena, Parczewski Milosz, Brännström Johanna, Sedlacek Dalibor, Degen Olaf, van der Valk Marc, Paduta Dzmitry, Flamholc Leo, Schmid Patrick, Orkin Chloe, Nielsen Lars N, Hoffmann Christian, Beniowski Marek, Oprea Cristiana, Begovac Josip, Peters Lars
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Chammartin F, Darling K, Abela I, Battegay M, Furrer H, Calmy A, Bernasconi E, Schmid P, Hoffmann M, Bucher H, and the Swiss HIV Cohort Study. CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2022; 91:508.
Sep 23, 2022CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
Sep 23, 2022J Acquir Immune Defic Syndr 2022; 91:508
Chammartin Frédérique, Darling Katharine, Abela Irene A, Battegay Manuel, Furrer Hansjakob, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Hoffmann Matthias, Bucher Heiner C, and the Swiss HIV Cohort Study
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B, Scherrer A, Darling K, Damas J, Bieler-Aeschlimann M, Hasse B, Schlosser L, Hachfeld A, Gutbrod K, Tarr P, Calmy A, Assal F, Kunze U, Stoeckle M, Schmid P, Rossi S, Di Benedetto C, Du Pasquier R, Cavassini M, Marzolini C, Hundsberger T. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus. Open Forum Infect Dis 2022; 9:ofac457.
Sep 2, 2022Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Sep 2, 2022Open Forum Infect Dis 2022; 9:ofac457
Jakeman Bernadette, Scherrer Alexandra U, Darling Katharine E A, Damas José, Bieler-Aeschlimann Melanie, Hasse Barbara, Schlosser Ladina, Hachfeld Anna, Gutbrod Klemens, Tarr Philip E, Calmy Alexandra, Assal Frédéric, Kunze Ursula, Stoeckle Marcel, Schmid Patrick, Rossi Stefania, Di Benedetto Caroline, Du Pasquier Renaud, Cavassini Matthias, Marzolini Catia, Hundsberger Thomas
Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study.
Mauri F, Cottler-Casanova S, Cavassini M, Stoeckle M, Wandeler G, Schmid P, Braun D, Scherrer A, Bernasconi E, Calmy A, Abdulcadir J. Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study. J Immigr Minor Health 2022; 25:136-141.
Aug 9, 2022Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study.
Aug 9, 2022J Immigr Minor Health 2022; 25:136-141
Mauri Fabio, Cottler-Casanova Sara, Cavassini Matthias, Stoeckle Marcel, Wandeler Gilles, Schmid Patrick, Braun Dominique L, Scherrer Alexandra, Bernasconi Enos, Calmy Alexandra, Abdulcadir Jasmine
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.
Kusejko K, Tschumi N, Chaudron S, Nguyen H, Battegay M, Bernasconi E, Böni J, Huber M, Calmy A, Cavassini M, Egle A, Grabmeier-Pfistershammer K, Haas B, Hirsch H, Klimkait T, Öllinger A, Perreau M, Ramette A, Flury B, Sarcletti M, Scherrer A, Schmid P, Yerly S, Zangerle R, Günthard H, Kouyos R. Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics. J Acquir Immune Defic Syndr 2022; 90:e4-e12.
Aug 1, 2022Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.
Aug 1, 2022J Acquir Immune Defic Syndr 2022; 90:e4-e12
Kusejko Katharina, Tschumi Nadine, Chaudron Sandra E, Nguyen Huyen, Battegay Manuel, Bernasconi Enos, Böni Jürg, Huber Michael, Calmy Alexandra, Cavassini Matthias, Egle Alexander, Grabmeier-Pfistershammer Katharina, Haas Bernhard, Hirsch Hans, Klimkait Thomas, Öllinger Angela, Perreau Matthieu, Ramette Alban, Flury Baharak Babouee, Sarcletti Mario, Scherrer Alexandra, Schmid Patrick, Yerly Sabine, Zangerle Robert, Günthard Huldrych F, Kouyos Roger D
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Bick A, Popadin K, Thorball C, Uddin M, Zanni M, Yu B, Cavassini M, Rauch A, Tarr P, Schmid P, Bernasconi E, Günthard H, Libby P, Boerwinkle E, McLaren P, Ballantyne C, Grinspoon S, Natarajan P, Fellay J, Swiss HIV Cohort Study. Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV. Sci Rep 2022; 12:11638.
Jul 8, 2022Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Jul 8, 2022Sci Rep 2022; 12:11638
Bick Alexander G, Popadin Konstantin, Thorball Christian W, Uddin Mesbah, Zanni Markella V, Yu Bing, Cavassini Matthias, Rauch Andri, Tarr Philip, Schmid Patrick, Bernasconi Enos, Günthard Huldrych F, Libby Peter, Boerwinkle Eric, McLaren Paul J, Ballantyne Christie M, Grinspoon Steven, Natarajan Pradeep, Fellay Jacques, Swiss HIV Cohort Study
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.
Jakeman B, Scherrer A, Battegay M, Günthard H, Hachfeld A, Calmy A, Schmid P, Bernasconi E, Cavassini M, Marzolini C. Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. J Antimicrob Chemother 2022; 77:492-499.
Feb 2, 2022Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.
Feb 2, 2022J Antimicrob Chemother 2022; 77:492-499
Jakeman Bernadette, Scherrer Alexandra, Battegay Manuel, Günthard Huldrych F, Hachfeld Anna, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Marzolini Catia
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
Damas J, Hundsberger T, Di Benedetto C, Rossi S, Hasse B, Schlosser L, Du Pasquier R, Darling K, Cavassini M, Schmid P, Assal F, Ledergerber B, Nadin I, Tarr P, Stoeckle M, Kunze U, Hauser C, Gutbrod K, Calmy A, and the NAMACO study group. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV. AIDS 2021; 35:2469-2480.
Dec 1, 2021Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
Dec 1, 2021AIDS 2021; 35:2469-2480
Damas José, Hundsberger Thomas, Di Benedetto Caroline, Rossi Stefania, Hasse Barbara, Schlosser Ladina, Du Pasquier Renaud, Darling Katharine E A, Cavassini Matthias, Schmid Patrick, Assal Frédéric, Ledergerber Bruno, Nadin Isaure, Tarr Philip E, Stoeckle Marcel, Kunze Ursi, Hauser Christoph, Gutbrod Klemens, Calmy Alexandra, and the NAMACO study group